WASHINGTON (Reuters) - The healthcare reform measure passed by the U.S. House of Representatives on Sunday delivers some good news for drugmakers, device companies and even health insurers.
Among the changes in the legislation was a provision delaying hefty taxes on those three industries by at least a year.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!